VTCN1 Antikörper (V-Set Domain Containing T Cell Activation Inhibitor 1) (AA 153-165) (FITC)

Details for Product anti-VTCN1 Antibody No. ABIN2386252
Target
Bindungsspezifität
AA 153-165, Internal Region
16
15
8
8
8
7
6
4
4
2
2
2
1
1
1
1
Reaktivität
Human
94
24
19
1
1
1
1
1
Wirt
Ziege
74
16
7
2
Klonalität
Polyklonal
Konjugat
Dieser VTCN1 Antikörper ist konjugiert mit FITC
12
11
8
7
3
3
2
2
2
2
2
2
1
1
1
1
1
Applikation
ELISA, Western Blotting (WB)
63
44
33
27
13
11
6
4
4
4
4
4
3
2
1
1
Optionen
Immunogen Synthetic peptide corresponding to aa153-165 from sequence C-PEVNVDYNASSET, at the internal region of the protein sequence according to NP_078902.2. Species sequence homology: mouse, rat, canine and bovine
Sequenz C-PEVNVDYNAS SET
Kreuzreaktivität Human
Kreuzreaktivität (Details) Calculated cross reactivity: Hu
Produktmerkmale VTCN1 (aa153-165) (B7h.5, B7H4, B7-H4, B7S1, B7X, FLJ22418, Immune costimulatory protein B7-H4, PRO1291, T cell costimulatory molecule B7x, T-cell costimulatory molecule B7x, VCTN1, V-set domain containing T cell activation inhibitor 1, V-set domain-containing T-cell activation inhibitor 1) (FITC)
Reinigung Purified by immunoaffinity chromatography.
Target
Andere Bezeichnung VTCN1 (VTCN1 Antibody Abstract)
NCBI Accession NP_078902
Applikations-hinweise Optimal working conditions should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Buffer Supplied as a liquid in Tris saline, pH 7.3, 0.02 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung -20 °C
Informationen zur Lagerung -20°C